Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Medical Biosciences,
Division of Immunotherapy,
Oncode Institute,
Department of Pathology,
Division of Immunotherapy, Oncode Institute
Kiek Verrijp has not added Biography.
If you are Kiek Verrijp and would like to personalize this page please email our Author Liaison for assistance.
Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers?
Biochimica et biophysica acta Aug, 2014 | Pubmed ID: 24747768
Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
Neuro-oncology Sep, 2016 | Pubmed ID: 27006175
Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytoma.
Scientific reports Jul, 2016 | Pubmed ID: 27460417
Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.
Acta neuropathologica communications Sep, 2016 | Pubmed ID: 27586084
In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150Glued.
Oncotarget 11, 2016 | Pubmed ID: 27689404
Selective MET Kinase Inhibition in MET-Dependent Glioma Models Alters Gene Expression and Induces Tumor Plasticity.
Molecular cancer research : MCR Nov, 2017 | Pubmed ID: 28751462
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome.
Journal for immunotherapy of cancer May, 2022 | Pubmed ID: 35550553
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination.
Journal for immunotherapy of cancer Oct, 2022 | Pubmed ID: 36252995
Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.
Cancers Nov, 2022 | Pubmed ID: 36497420
Radboudumc
Mark A. J. Gorris1,2,
Evgenia Martynova*,1,3,
Mark W. D. Sweep*,1,4,
Iris A. E. van der Hoorn1,5,
Shabaz Sultan1,3,
Mike J. D. E. Claassens1,
Lieke L. van der Woude1,2,6,
Kiek Verrijp1,2,6,
Carl G. Figdor1,3,
Johannes Textor1,3,
I. Jolanda M. de Vries1
1Department of Medical BioSciences, Radboudumc,
2Division of Immunotherapy, Oncode Institute, Radboudumc,
3Data Science, Institute for Computing and Information Sciences, Radboud University,
4Department of Medical Oncology, Radboudumc,
5Department of Pulmonary Diseases, Radboudumc,
6Department of Pathology, Radboudumc
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved